ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi Limited as shareholders, announced results...
Read moreDogs suffering from cardiovascular disease and related clinical signs will officially have an opportunity for a better and longer life,...
Read moreIn this role Nicholas will lead Johnson Matthey's (JM) custom development and manufacturing offering to pharmaceutical and biotechnology customers who...
Read more
GlaxoSmithKline has won U.S. approval for a new and improved shingles vaccine, the second of three key products for which...
Read more
We are pleased to announce the appointment of Nicholas Shackley to the role of Global Vice President Innovator Products and...
Read moreAstellas Pharma Inc. announced that the U.S. FDA has granted Fast Track designation for the development of gilteritinib for adult...
Read more
Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing announced the launch of its Accel-Amplicon™ Custom...
Read more
Juno Therapeutics, Inc. a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today unveiled its new headquarters...
Read more
GlaxoSmithKline plc and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily,...
Read more
Belgium-based CDMO Kaneka Eurogentec, a unit of Japanese chemical giant Kaneka, will build a new biologics manufacturing facility as part...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
